Fresh ATAGI vax advice gives GPs ‘clarity’ amid Sydney outbreak

Associate Professor Charlotte Hespe welcomes the move that 'supports GPs'
Associate Professor Charlotte Hespe
Associate Professor Charlotte Hespe.

Patients under 60 in Sydney and other COVID-19 hotspots should consider getting the AstraZeneca vaccine if they’re unable to access the Pfizer option, Australia’s peak immunisation advisory body says.

The Australian Technical Advisory Group on Immunisation (ATAGI) also clarifies that patients, including over-60s, can receive the second dose of the viral-vector vaccine 4-8 weeks after the first dose rather than 12 weeks.